Cargando…
4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543014/ https://www.ncbi.nlm.nih.gov/pubmed/32628062 http://dx.doi.org/10.1177/1352458520923951 |
| _version_ | 1783591652846206976 |
|---|---|
| author | Strijbis, Eva MM Nij Bijvank, Jenny A Killestein, Joep |
| author_facet | Strijbis, Eva MM Nij Bijvank, Jenny A Killestein, Joep |
| author_sort | Strijbis, Eva MM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7543014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75430142020-10-14 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes Strijbis, Eva MM Nij Bijvank, Jenny A Killestein, Joep Mult Scler Controversies in Multiple Sclerosis SAGE Publications 2020-07-06 2020-10 /pmc/articles/PMC7543014/ /pubmed/32628062 http://dx.doi.org/10.1177/1352458520923951 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Controversies in Multiple Sclerosis Strijbis, Eva MM Nij Bijvank, Jenny A Killestein, Joep 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title_full | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title_fullStr | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title_full_unstemmed | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title_short | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes |
| title_sort | 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – yes |
| topic | Controversies in Multiple Sclerosis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543014/ https://www.ncbi.nlm.nih.gov/pubmed/32628062 http://dx.doi.org/10.1177/1352458520923951 |
| work_keys_str_mv | AT strijbisevamm 4aminopyridineisnotjustasymptomatictherapyithasaneuroprotectiveeffectyes AT nijbijvankjennya 4aminopyridineisnotjustasymptomatictherapyithasaneuroprotectiveeffectyes AT killesteinjoep 4aminopyridineisnotjustasymptomatictherapyithasaneuroprotectiveeffectyes |